Overall rank by patents
#36,102
Across all tracked assignees
USPTO PatentsView assignee record — 7 granted patents across 6 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).
KOYA MEDICAL, INC. has been granted 7 US utility patents between 2022 and 2025, placing KOYA MEDICAL, INC. at rank #36,102 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.6 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, KOYA MEDICAL, INC. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 47.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. KOYA MEDICAL, INC.'s 19.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark KOYA MEDICAL, INC. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
KOYA MEDICAL, INC.
7 patents
What this shows KOYA holds 7 patents — placing it at rank #36,102 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 1 | 14.3% |
| 2023 | 3 | 42.9% |
| 2024 | 2 | 28.6% |
| 2025 | 1 | 14.3% |
Top 6 of 6 technology areas
Overall rank by patents
#36,102
Across all tracked assignees
47.6 out of 100
KOYA MEDICAL, INC.'s primary CPC class — all holders and yearly trends
See where KOYA MEDICAL, INC. ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.